 Law.com Eli Lilly has filed six lawsuits, including five in Texas, against companies it says are illegally selling unapproved versions of its experimental weight-loss drug retatrutide amid growing concern over a global black market for counterfeit and compounded obesity treatments. 
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. | 
